Medicaid Formulary Decisions: Shift To MCOs May Limit Pharma Input – Study
Executive Summary
Drug firms may find it harder to contribute to Medicaid formulary decisions in the coming years as state programs increasingly turn to managed care organizations to handle their pharmacy benefits, according to a recent research report by Avalere Health and the Kaiser Commission on Medicaid and the Uninsured.